Suppr超能文献

黑热病管理中的问题:来自比哈尔邦的经验

PROBLEMS IN MANAGEMENT OF KALA AZAR: EXPERIENCE FROM BIHAR.

作者信息

Rai S P, Bandyopadhyay S

机构信息

Classified Specialist (Medicine and Respiratory Medicine), Army Hospital (R&R) Delhi Cantt -110010.

Reader, Department of Biochemistry, Armed Forces Medical College, Pune - 411 040.

出版信息

Med J Armed Forces India. 2001 Apr;57(2):117-9. doi: 10.1016/S0377-1237(01)80128-3. Epub 2011 Jul 21.

Abstract

35 cases of Kala-Azar were managed at 200 bedded peripheral hospital, Bihar from Jan 1994 to Jan 1998. Patients presenting with history of fever for more than 3 weeks duration with splenomegaly or hepatosplenomegaly were investigated for Kala-Azar. A confirmative diagnosis of Kala-Azar was made in all cases by demonstrating Leishmania amastigote (LD body) in bone marrow or splenic aspirate. All patients were initially treated by sodium stibogluconate (SSG) 20 mg/kg body wt daily for 20 to 40 days depending on response. SSG induced cardiac toxicity was seen in 6 cases (VT-2, ST-T changes-2, QTc Prolongation-2) out of which 1 patient died of refractory ventricular tachyacarida. 9 patients were unresponsive to SSG,8 patients were treated with pentamidine isoethionate (4 mg/kg body wt IV alternate day) 10-15 dosage. 1 patient was treated with amphotericin-B. All the patients showed clinical and parasitological improvement and no relapse was noted at 6 month follow up. 6 patients had associated tuberculosis (Disseminated TB-2, Miliary TB-1, Pulmonary TB-1. Pleural TB-2). 2 patients had associated pneumonia, 1 patient had HIV infection and 1 patient had erythema nodosum leperosum.

摘要

1994年1月至1998年1月期间,在比哈尔邦一家拥有200张床位的外围医院对35例黑热病患者进行了治疗。对有持续3周以上发热史并伴有脾肿大或肝脾肿大的患者进行了黑热病调查。所有病例均通过在骨髓或脾穿刺物中发现利什曼原虫无鞭毛体(LD小体)而确诊为黑热病。所有患者最初均接受葡萄糖酸锑钠(SSG)治疗,剂量为每日20mg/kg体重,持续20至40天,具体疗程视反应而定。6例患者出现了SSG诱发的心脏毒性(室性心动过速2例、ST-T改变2例、QTc延长2例),其中1例患者死于难治性室性心动过速。9例患者对SSG无反应,8例患者接受了异硫氰酸喷他脒(4mg/kg体重,静脉注射,隔日1次)治疗,共10 - 15次剂量。1例患者接受了两性霉素B治疗。所有患者的临床症状和寄生虫学表现均有改善,在6个月的随访中未发现复发。6例患者合并有结核病(播散性结核2例、粟粒性结核1例、肺结核1例、结核性胸膜炎2例)。2例患者合并有肺炎,1例患者感染了HIV,1例患者患有麻风结节性红斑。

相似文献

1
PROBLEMS IN MANAGEMENT OF KALA AZAR: EXPERIENCE FROM BIHAR.
Med J Armed Forces India. 2001 Apr;57(2):117-9. doi: 10.1016/S0377-1237(01)80128-3. Epub 2011 Jul 21.
2
Amphotericin B in resistant kala-azar in Bihar.
Natl Med J India. 1993 Mar-Apr;6(2):57-60.
3
6
A new strategy for elimination of kala-azar from rural Bihar.
Indian J Med Res. 2007 Nov;126(5):447-51.
7
Drug unresponsiveness & combination therapy for kala-azar.
Indian J Med Res. 2006 Mar;123(3):389-98.
9
Amphotericin B therapy in kala-azar.
J Indian Med Assoc. 1993 Apr;91(4):91-3.
10
Rationalisation of regimens of treatment of kala-azar with sodium stibogluconate in India: a randomised study.
Br Med J (Clin Res Ed). 1988 Jun 4;296(6636):1557-61. doi: 10.1136/bmj.296.6636.1557.

本文引用的文献

3
The leishmaniases. Report of a WHO Expert Committee.
World Health Organ Tech Rep Ser. 1984;701:1-140.
4
Comparison of regimens of treatment with sodium stibogluconate in kala-azar.
Br Med J (Clin Res Ed). 1984 Mar 24;288(6421):895-7. doi: 10.1136/bmj.288.6421.895.
5
Prolonged sodium stibogluconate therapy in Indian kala-azar.
J Assoc Physicians India. 1986 Jul;34(7):469-71.
6
Rationalisation of regimens of treatment of kala-azar with sodium stibogluconate in India: a randomised study.
Br Med J (Clin Res Ed). 1988 Jun 4;296(6636):1557-61. doi: 10.1136/bmj.296.6636.1557.
7
Kala-azar mortality in hospitalized cases in north Bihar, India.
J Assoc Physicians India. 1989 Aug;37(8):514-6.
9
Comparison of regimes of treatment of antimony-resistant kala-azar patients: a randomized study.
Am J Trop Med Hyg. 1991 Oct;45(4):435-41. doi: 10.4269/ajtmh.1991.45.435.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验